Ferriprotoporphyrin IX (Hemin) (Fe(III)PPIX)

Hemin, chemically known as ferriprotoporphyrin IX, is a toxic byproduct generated during the intraerythrocytic stage of the Plasmodium life cycle (NCBI: PMC3111555). As the malaria parasite digests host hemoglobin within its acidic digestive vacuole to obtain essential amino acids, it releases large quantities of free heme (PubMed: 11514513). To prevent heme-induced oxidative damage and membrane lysis, the parasite detoxifies this molecule by polymerizing it into an insoluble, non-toxic crystalline form known as hemozoin, or malaria pigment (ScienceDirect: Hemozoin). This biocrystallization process is a critical survival mechanism and serves as a primary target for several classes of antimalarial drugs, most notably the 4-aminoquinolines like chloroquine and the cinchona alkaloids like quinine (DrugBank: DB00608). These drugs interact with hemin or the growing hemozoin crystals to prevent further polymerization, leading to the accumulation of toxic free heme which disrupts parasite membranes and enzymatic functions (Nature: 10.1038/s41598-017-14198-x). Consequently, the buildup of these toxic intermediates leads to the rapid death of the parasite within the host red blood cell. The effectiveness of targeting this pathway is challenged by the emergence of resistance mechanisms, such as mutations in the PfCRT transporter that efflux drugs from the digestive vacuole (NCBI: PMC2823315).

Other names

HeminHematinHemeFerriprotoporphyrin IXFPMalaria pigment precursor

Inhibition of heme biocrystallization (hemozoin formation), leading to the accumulation of toxic free ferriprotoporphyrin IX which causes oxidative damage and membrane lysis in the parasite.